The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.
The Need for Multi-Omics Biomarker Signatures in Precision Medicine
Open accessAbstract
Recent advances in omics technologies have led to unprecedented efforts characterizing the molecular changes that underlie the development and progression of a wide array of complex human diseases, including cancer. As a result, multi-omics analyses—which take advantage of these technologies in genomics, transcriptomics, epigenomics, proteomics, metabolomics, and other omics areas—have been proposed and heralded as the key to advancing precision medicine in the clinic. In the field of precision oncology, genomics approaches, and, more recently, other omics analyses have helped reveal several key mechanisms in cancer development, treatment resistance, and recurrence risk, and several of these findings have been implemented in clinical oncology to help guide treatment decisions. However, truly integrated multi-omics analyses have not been applied widely, preventing further advances in precision medicine. Additional efforts are needed to develop the analytical infrastructure necessary to generate, analyze, and annotate multi-omics data effectively to inform precision medicine-based decision-making.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WGCNA: an R package for weighted correlation network analysis
Langfelder, P., & Horvath, S. (2008) · BMC Bioinformatics · doi:10.1186/1471-2105-9-559 · Cited by 27,252
Signatures of mutational processes in human cancer
Initiative, A. P. C. G., Alexandrov, L. B., ICGC Breast Cancer Consortium, ICGC MMML-Seq Consortium, PedBrain, I., Nik-Zainal, S., Wedge, D. C., Aparicio, S. A. J. R., Behjati, S., Biankin, A. V., et al. (2013) · Nature · doi:10.1038/nature12477 · Cited by 9,660
The cancer genome atlas pan-cancer analysis project
The Cancer Genome Atlas Research Network, Weinstein, J. N., Collisson, E. A., Mills, G. B., Shaw, K. R. M., Ozenberger, B. A., Ellrott, K., Shmulevich, I., Sander, C., & Stuart, J. M. (2013) · Nature Genetics · doi:10.1038/ng.2764 · Cited by 9,092
MGMT Gene Silencing and Benefit from Temozolomide in Glioblastoma
Hegi, M. E., Diserens, A.-C., Gorlia, T., Hamou, M.-F., de Tribolet, N., Weller, M., Kros, J. M., Hainfellner, J. A., Mason, W., Mariani, L., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043331 · Cited by 7,405
Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq
Tirosh, I., Izar, B., Prakadan, S. M., Wadsworth, M. H., Treacy, D., Trombetta, J. J., Rotem, A., Rodman, C., Lian, C., Murphy, G., et al. (2016) · Science · doi:10.1126/science.aad0501 · Cited by 4,944
Integrative Clinical Genomics of Advanced Prostate Cancer
Robinson, D., Van Allen, E. M., Wu, Y.-M., Schultz, N., Lonigro, R. J., Mosquera, J.-M., Montgomery, B., Taplin, M.-E., Pritchard, C. C., Attard, G., et al. (2015) · Cell · doi:10.1016/j.cell.2015.05.001 · Cited by 3,645
Review The Cancer Genome Atlas (TCGA): an immeasurable source of knowledge
Tomczak, K., Czerwińska, P., & Wiznerowicz, M. (2015) · Współczesna Onkologia · doi:10.5114/wo.2014.47136 · Cited by 3,492
The Human Connectome: A Structural Description of the Human Brain
Sporns, O., Tononi, G., & Kötter, R. (2005) · PLoS Computational Biology · doi:10.1371/journal.pcbi.0010042 · Cited by 3,260
Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas
The Cancer Genome Atlas Research Network (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1402121 · Cited by 3,148
Multi-omics approaches to disease
Hasin, Y., Seldin, M., & Lusis, A. (2017) · Genome Biology · doi:10.1186/s13059-017-1215-1 · Cited by 2,953
Long Noncoding RNA and Cancer: A New Paradigm
Bhan, A., Soleimani, M., & Mandal, S. S. (2017) · Cancer Research · doi:10.1158/0008-5472.can-16-2634 · Cited by 2,861
Mass-spectrometric exploration of proteome structure and function
Aebersold, R., & Mann, M. (2016) · Nature · doi:10.1038/nature19949 · Cited by 2,334
The causes and consequences of genetic heterogeneity in cancer evolution
Burrell, R. A., McGranahan, N., Bartek, J., & Swanton, C. (2013) · Nature · doi:10.1038/nature12625 · Cited by 2,262
Comprehensive Characterization of Cancer Driver Genes and Mutations
Bailey, M. H., Tokheim, C., Porta-Pardo, E., Sengupta, S., Bertrand, D., Weerasinghe, A., Colaprico, A., Wendl, M. C., Kim, J., Reardon, B., et al. (2018) · Cell · doi:10.1016/j.cell.2018.02.060 · Cited by 2,256
Pan-cancer patterns of somatic copy number alteration
Zack, T. I., Schumacher, S. E., Carter, S. L., Cherniack, A. D., Saksena, G., Tabak, B., Lawrence, M. S., Zhang, C.-Z., Wala, J., Mermel, C. H., et al. (2013) · Nature Genetics · doi:10.1038/ng.2760 · Cited by 1,870
LncRNA-mediated regulation of cell signaling in cancer
Peng, W.-X., Koirala, P., & Mo, Y.-Y. (2017) · Oncogene · doi:10.1038/onc.2017.184 · Cited by 1,661
Kulis, M., & Esteller, M. (2010) · Advances in Genetics · doi:10.1016/b978-0-12-380866-0.60002-2 · Cited by 1,566
Untargeted Metabolomics Strategies—Challenges and Emerging Directions
Schrimpe-Rutledge, A. C., Codreanu, S. G., Sherrod, S. D., & McLean, J. A. (2016) · Journal of the American Society for Mass Spectrometry · doi:10.1007/s13361-016-1469-y · Cited by 1,372
Davoli, T., Uno, H., Wooten, E. C., & Elledge, S. J. (2017) · Science · doi:10.1126/science.aaf8399 · Cited by 1,360
The emerging field of lipidomics
Wenk, M. R. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1776 · Cited by 1,330
Metagenomics: Genomic Analysis of Microbial Communities
Riesenfeld, C. S., Schloss, P. D., & Handelsman, J. (2004) · Annual Review of Genetics · doi:10.1146/annurev.genet.38.072902.091216 · Cited by 1,129
Histone Modifications and Cancer
Audia, J. E., & Campbell, R. M. (2016) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a019521 · Cited by 1,024
Proteomics: Technologies and Their Applications
Aslam, B., Basit, M., Nisar, M. A., Khurshid, M., & Rasool, M. H. (2017) · Journal of Chromatographic Science · doi:10.1093/chromsci/bmw167 · Cited by 1,000
Single-cell RNA-seq enables comprehensive tumour and immune cell profiling in primary breast cancer
Chung, W., Eum, H. H., Lee, H.-O., Lee, K.-M., Lee, H.-B., Kim, K.-T., Ryu, H. S., Kim, S., Lee, J. E., Park, Y. H., et al. (2017) · Nature Communications · doi:10.1038/ncomms15081 · Cited by 992
The Chronic Myelogenous Leukemia-Specific P210 Protein Is the Product of the bcr / abl Hybrid Gene
Ben-Neriah, Y., Daley, G. Q., Mes-Masson, A.-M., Witte, O. N., & Baltimore, D. (1986) · Science · doi:10.1126/science.3460176 · Cited by 806
Landscape of Somatic Retrotransposition in Human Cancers
Lee, E., Iskow, R., Yang, L., Gokcumen, O., Haseley, P., Luquette, L. J., Lohr, J. G., Harris, C. C., Ding, L., Wilson, R. K., et al. (2012) · Science · doi:10.1126/science.1222077 · Cited by 762
Integrated omics: tools, advances and future approaches
Misra, B. B., Langefeld, C., Olivier, M., & Cox, L. A. (2019) · Journal of Molecular Endocrinology · doi:10.1530/jme-18-0055 · Cited by 686 · cited 1×
“Additional tools will be needed to perform these complex integrated analyses using strict statistical models, and to help in the interpretation and biological annotation of the obtained co-expression networks or clusters of multi-omics analytes [77].”
MethodMayers, J. R., Wu, C., Clish, C. B., Kraft, P., Torrence, M. E., Fiske, B. P., Yuan, C., Bao, Y., Townsend, M. K., Tworoger, S. S., et al. (2014) · Nature Medicine · doi:10.1038/nm.3686 · Cited by 649
Driver Fusions and Their Implications in the Development and Treatment of Human Cancers
Gao, Q., Liang, W.-W., Foltz, S. M., Mutharasu, G., Jayasinghe, R. G., Cao, S., Liao, W.-W., Reynolds, S. M., Wyczalkowski, M. A., Yao, L., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.050 · Cited by 604
Multi-omic and multi-view clustering algorithms: review and cancer benchmark
Rappoport, N., & Shamir, R. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky889 · Cited by 553
Transcriptome analysis using next-generation sequencing
Mutz, K.-O., Heilkenbrinker, A., Lönne, M., Walter, J.-G., & Stahl, F. (2013) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2012.09.004 · Cited by 535
A Longitudinal Big Data Approach for Precision Health
Schüssler-Fiorenza Rose, S. M., Contrepois, K., Moneghetti, K. J., Zhou, W., Mishra, T., Mataraso, S., Dagan-Rosenfeld, O., Ganz, A. B., Dunn, J., Hornburg, D., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0414-6 · Cited by 494
Single-Cell RNA Sequencing in Cancer: Lessons Learned and Emerging Challenges
Suvà, M. L., & Tirosh, I. (2019) · Molecular Cell · doi:10.1016/j.molcel.2019.05.003 · Cited by 476
Sun, Y. V., & Hu, Y.-J. (2016) · Advances in Genetics · doi:10.1016/bs.adgen.2015.11.004 · Cited by 459 · cited 1×
“Indeed, this suggestion is not specific to the field of cancer research, and other human diseases would likely benefit from similar approaches [80].”
BackgroundGrabiner, B. C., Nardi, V., Birsoy, K., Possemato, R., Shen, K., Sinha, S., Jordan, A., Beck, A. H., & Sabatini, D. M. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0929 · Cited by 450
Glycomics: an integrated systems approach to structure-function relationships of glycans
Raman, R., Raguram, S., Venkataraman, G., Paulson, J. C., & Sasisekharan, R. (2005) · Nature Methods · doi:10.1038/nmeth807 · Cited by 439
Genome-wide association studies of cancer: current insights and future perspectives
Sud, A., Kinnersley, B., & Houlston, R. S. (2017) · Nature Reviews Cancer · doi:10.1038/nrc.2017.82 · Cited by 393
Botling, J., Edlund, K., Lohr, M., Hellwig, B., Holmberg, L., Lambe, M., Berglund, A., Ekman, S., Bergqvist, M., Pontén, F., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1139 · Cited by 359
Washburn, M. P., Koller, A., Oshiro, G., Ulaszek, R. R., Plouffe, D., Deciu, C., Winzeler, E., & Yates, J. R. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0634629100 · Cited by 354
Cifuentes, A. (2009) · Journal of Chromatography A · doi:10.1016/j.chroma.2009.09.018 · Cited by 320
Integrative eQTL-Based Analyses Reveal the Biology of Breast Cancer Risk Loci
Li, Q., Seo, J.-H., Stranger, B., McKenna, A., Pe’er, I., LaFramboise, T., Brown, M., Tyekucheva, S., & Freedman, M. L. (2013) · Cell · doi:10.1016/j.cell.2012.12.034 · Cited by 308
Practical implications of gene-expression-based assays for breast oncologists
Prat, A., Ellis, M. J., & Perou, C. M. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.178 · Cited by 295
From profiles to function in epigenomics
Stricker, S. H., Köferle, A., & Beck, S. (2017) · Nature Reviews Genetics · doi:10.1038/nrg.2016.138 · Cited by 289
Wagle, N., Grabiner, B. C., Van Allen, E. M., Hodis, E., Jacobus, S., Supko, J. G., Stewart, M., Choueiri, T. K., Gandhi, L., Cleary, J. M., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0353 · Cited by 281
Shotgun lipidomics: multidimensional MS analysis of cellular lipidomes
Han, X., & Gross, R. W. (2005) · Expert Review of Proteomics · doi:10.1586/14789450.2.2.253 · Cited by 278
Inherited TP53 Mutations and the Li–Fraumeni Syndrome
Guha, T., & Malkin, D. (2017) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a026187 · Cited by 253
Whole transcriptome analysis with sequencing: methods, challenges and potential solutions
Jiang, Z., Zhou, X., Li, R., Michal, J. J., Zhang, S., Dodson, M. V., Zhang, Z., & Harland, R. M. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1934-y · Cited by 235
Integrative Personal Omics Profiles during Periods of Weight Gain and Loss
Piening, B. D., Zhou, W., Contrepois, K., Röst, H., Gu Urban, G. J., Mishra, T., Hanson, B. M., Bautista, E. J., Leopold, S., Yeh, C. Y., et al. (2018) · Cell Systems · doi:10.1016/j.cels.2017.12.013 · Cited by 212
Mutant IDH1 promotes leukemogenesis in vivo and can be specifically targeted in human AML
Chaturvedi, A., Araujo Cruz, M. M., Jyotsana, N., Sharma, A., Yun, H., Görlich, K., Wichmann, M., Schwarzer, A., Preller, M., Thol, F., et al. (2013) · Blood · doi:10.1182/blood-2013-03-491571 · Cited by 210 · cited 1×
“The limited studies in cancer biology have identified some putative metabolic biomarkers, such as altered carbohydrates in acute myeloid leukemia [69], and unsaturated free fatty acids in colorectal cancer [70].”
BackgroundBRCA1 and BRCA2 mutations across race and ethnicity: distribution and clinical implications
Kurian, A. W. (2010) · Current Opinion in Obstetrics & Gynecology · doi:10.1097/gco.0b013e328332dca3 · Cited by 200
MicroRNAs as mediators and communicators between cancer cells and the tumor microenvironment
Kohlhapp, F. J., Mitra, A. K., Lengyel, E., & Peter, M. E. (2015) · Oncogene · doi:10.1038/onc.2015.89 · Cited by 200
Spermine and Citrate as Metabolic Biomarkers for Assessing Prostate Cancer Aggressiveness
Giskeødegård, G. F., Bertilsson, H., Selnæs, K. M., Wright, A. J., Bathen, T. F., Viset, T., Halgunset, J., Angelsen, A., Gribbestad, I. S., & Tessem, M.-B. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062375 · Cited by 182
Epigenomics: Technologies and Applications
Wang, K. C., & Chang, H. Y. (2018) · Circulation Research · doi:10.1161/circresaha.118.310998 · Cited by 169
Dissecting intratumoral myeloid cell plasticity by single cell RNA-seq
Song, Q., Hawkins, G. A., Wudel, L., Chou, P., Forbes, E., Pullikuth, A. K., Liu, L., Jin, G., Craddock, L., Topaloglu, U., et al. (2019) · Cancer Medicine · doi:10.1002/cam4.2113 · Cited by 168
Self-citationA protein and mRNA expression-based classification of gastric cancer
Setia, N., Agoston, A. T., Han, H. S., Mullen, J. T., Duda, D. G., Clark, J. W., Deshpande, V., Mino-Kenudson, M., Srivastava, A., Lennerz, J. K., et al. (2016) · Modern Pathology · doi:10.1038/modpathol.2016.55 · Cited by 162
Teplyuk, N. M., Uhlmann, E. J., Gabriely, G., Volfovsky, N., Wang, Y., Teng, J., Karmali, P. P., Marcusson, E. G., Peter, M., Mohan, A., et al. (2016) · EMBO Molecular Medicine · doi:10.15252/emmm.201505495 · Cited by 151
Branched-chain amino acids as biomarkers in diabetes
Giesbertz, P., & Daniel, H. (2015) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0000000000000235 · Cited by 133
Duarte, C. W., Willey, C. D., Zhi, D., Cui, X., Harris, J. J., Vaughan, L. K., Mehta, T. S., McCubrey, R. O., Khodarev, N. N., Weichselbaum, R. R., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0029653 · Cited by 133
Horning, A. M., Wang, Y., Lin, C.-K., Louie, A. D., Jadhav, R. R., Hung, C., Wang, C., Lin, C.-L., Kirma, N. B., Liss, M. A., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-1924 · Cited by 129
The wholeness in suffix -omics, -omes, and the word om.
Yadav, S. P. (2007) · PubMed · Cited by 119
Novel Applications of Metabolomics in Personalized Medicine: A Mini-Review
Li, B., He, X., Jia, W. P., & Li, H. (2017) · Molecules · doi:10.3390/molecules22071173 · Cited by 114
Fehringer, G., Kraft, P., Pharoah, P. D. P., Eeles, R. A., Chatterjee, N., Schumacher, F. R., Schildkraut, J. M., Lindström, S., Brennan, P., Bickeböller, H., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-15-2980 · Cited by 112
On the utilization of polygenic risk scores for therapeutic targeting
Gibson, G. C. (2019) · PLoS Genetics · doi:10.1371/journal.pgen.1008060 · Cited by 107
Epigenetics and pancreatic cancer: Pathophysiology and novel treatment aspects
Neureiter, D. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i24.7830 · Cited by 100
Clinical Proteomics of Breast Cancer Reveals a Novel Layer of Breast Cancer Classification
Yanovich, G., Agmon, H., Harel, M., Sonnenblick, A., Peretz, T., & Geiger, T. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1079 · Cited by 98
A Network-Based Cancer Drug Discovery: From Integrated Multi-Omics Approaches to Precision Medicine
Turanlı, B., Karagoz, K., Gülfidan, G., et al. (2019) · Current Pharmaceutical Design · doi:10.2174/1381612824666181106095959 · Cited by 83
Mismatch repair genes in Lynch syndrome: a review
da Silva, F. C. C., Dominguez–Valentin, M., Ferreira, F. D. O., Carraro, D. M., & Rossi, B. M. (2009) · Sao Paulo Medical Journal · doi:10.1590/s1516-31802009000100010 · Cited by 81
Foodomics for human health: current status and perspectives
Braconi, D., Bernardini, G., Millucci, L., & Santucci, A. (2017) · Expert Review of Proteomics · doi:10.1080/14789450.2018.1421072 · Cited by 74
Cantafio, M. E. G., Grillone, K., Caracciolo, D., Scionti, F., Arbitrio, M., Barbieri, V., Pensabene, L., Guzzi, P. H., & Martino, M. T. D. (2018) · Microarrays · doi:10.3390/ht7040033 · Cited by 71
Cis-eQTL-based trans-ethnic meta-analysis reveals novel genes associated with breast cancer risk
Hoffman, J., Graff, R. E., Emami, N. C., Tai, C. G.-L., Passarelli, M. N., Hu, D., Huntsman, S., Hadley, D., Leong, L., Majumdar, A., et al. (2017) · PLoS Genetics · doi:10.1371/journal.pgen.1006690 · Cited by 66
Personal Omics for Precision Health
Kellogg, R. A., Dunn, J., & Snyder, M. P. (2018) · Circulation Research · doi:10.1161/circresaha.117.310909 · Cited by 66
Integrative Analysis of Longitudinal Metabolomics Data from a Personal Multi-Omics Profile
Stanberry, L. I., Mias, G. I., Haynes, W. A., Higdon, R., Snyder, M. P., & Kolker, E. (2013) · Metabolites · doi:10.3390/metabo3030741 · Cited by 63
A brief review of single-cell transcriptomic technologies
Tomer Kalisky, C., Oriel, S., Bar-Lev, T. H., Ben-Haim, N., Trink, A., Wineberg, Y., Kanter, I., Gilad, S., & Pyne, S. (2017) · Briefings in Functional Genomics · doi:10.1093/bfgp/elx019 · Cited by 62
Cell chips as new tools for cell biology – results, perspectives and opportunities
Primiceri, E., Chiriacò, M. S., Rinaldi, R., & Maruccio, G. (2013) · Lab on a Chip · doi:10.1039/c3lc50550b · Cited by 61
Cruz, I. N., Coley, H. M., Kramer, H., Madhuri, T. K., Safuwan, N. A. M., ANGELINO, A. R., & Yang, M. (2017) · Cancer Genomics & Proteomics · doi:10.21873/cgp.20017 · Cited by 61
Ali, M., Khan, S. A., Wennerberg, K., & Aittokallio, T. A. (2017) · Bioinformatics · doi:10.1093/bioinformatics/btx766 · Cited by 59
Epigenetics and miRNA as predictive markers and targets for lung cancer chemotherapy
El‐Awady, R., Hersi, F., Al-Tunaiji, H., Saleh, E., Wahab, A. H. A. A., Homssi, A. A., Suhail, M., El-Serafi, A. T., & Al‐Tel, T. H. (2015) · Cancer Biology & Therapy · doi:10.1080/15384047.2015.1046023 · Cited by 54
Understanding Ovarian Cancer: iTRAQ-Based Proteomics for Biomarker Discovery
Światły‐Błaszkiewicz, A., Horała, A., Matysiak, J., Hajduk, J., Nowak‐Markwitz, E., & Kokot, Z. J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19082240 · Cited by 36
Molecular classification of glioma
Killock, D. (2015) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2015.111 · Cited by 30
Branched-Chain Amino Acids and Cardiovascular Disease: Does Diet Matter?
Ferguson, J. F., & Wang, T. J. (2016) · Clinical Chemistry · doi:10.1373/clinchem.2016.254318 · Cited by 27
Li, W., Wang, R., Yan, Z., Bai, L., & Sun, Z. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033653 · Cited by 12
Li, W., Wang, R., Yan, Z., Bai, L., & Sun, Z. (2012) · PLoS ONE · doi:10.1371/annotation/59a30e2e-76cf-4b51-9489-5bf0c2394afb · Cited by 1
Cited by
Applications of multi‐omics analysis in human diseases
Chen, C., Wang, J., Pan, D., Wang, X., Xu, Y., Yan, J., Wang, L., Yang, X., Yang, M., & Liu, G. (2023) · MedComm · doi:10.1002/mco2.315 · Cited by 545
A roadmap for multi-omics data integration using deep learning
Kang, M., Ko, E., & Mersha, T. B. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbab454 · Cited by 389
After another decade: LC–MS/MS became routine in clinical diagnostics
Seger, C., & Salzmann, L. (2020) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2020.03.004 · Cited by 301
AI-Assisted Detection of Biomarkers by Sensors and Biosensors for Early Diagnosis and Monitoring
Wasilewski, T., Kamysz, W., & Gębicki, J. (2024) · Biosensors · doi:10.3390/bios14070356 · Cited by 290
Nakayasu, E. S., Gritsenko, M., Piehowski, P. D., Gao, Y., Orton, D. J., Schepmoes, A. A., Fillmore, T. L., Frohnert, B. I., Rewers, M., Krischer, J. P., et al. (2021) · Nature Protocols · doi:10.1038/s41596-021-00566-6 · Cited by 275
Metadata
- Authors
- Olivier, M., Asmis, R., Hawkins, G. A., Howard, T. D., & Cox, L. A.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-09-26
- Volume
- 20
- Issue
- 19
- Pages
- 4781
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2976952765
- Cited by
- 499
- References
- 83
- FWCI
- 14.61
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.